Perth-based biotechnology company pSivida Ltd will raise $3.7 million through a placement to Australian and European investors, to fund development of its macular edema treatment.
20/12/2006 - 10:41
pSivida raises $3.7m, re-appoints Aston to board
20/12/2006 - 10:41
